SAN FRANCISCO, November 14, 2018 /PRNewswire/ --
The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come.
Diagnostics, when combined with nuclear medicine, improve accuracy to a great extent. This can have a direct impact on decision-making and treatment monitoring processes. Adoption of PET as a diagnostic tool is rapidly increasing since it has shown greater precision over other diagnostic techniques.
Browse full research report with TOC on "Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market
Further Key Findings From the Report Suggest:
- By product, the nuclear medicine market was dominated by the diagnostic segment in 2015, driven primarily by advancements in scanning technologies
- The therapeutic segment, which comprises alpha emitters, beta emitters, and brachytherapy, is anticipated to exhibit lucrative growth over the coming years
- On the basis of application, diagnostic formed the largest segment in 2015, including key areas such as cardiology, neurology, oncology, and thyroid
- North America dominated the global radiopharmaceuticals market in 2015 owing to well-planned policies, favorable reimbursement structure, high healthcare spending, and increasing awareness
- Asia Pacific is expected to witness lucrative growth in the coming years. Increasing per capita income and reform in policies is attracting market players
- Key players in the industry include Eckert & Ziegler Group; Mallinckrodt Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A; and Nordion, Inc.
Browse related reports by Grand View Research:
- Genitourinary Drugs Market - The global genitourinary drugs market accounted for USD 28.2 billion in 2015 and is anticipated to grow at a CAGR of over 0.8% during the forecast period.
- Doxorubicin Market - The global doxorubicin market size was valued at USD 809.6 million in 2015 and is projected to grow at a CAGR of 6.4% over the forecast period.
- Antifungal Drugs Market - The global antifungal drugs market size was valued at USD 10.7 billion in 2015.
- Multiple Myeloma Therapeutics Market - The global multiple myeloma therapeutics market was valued at USD 7.5 billion in 2015 and is projected to grow at a CAGR of 16.6% over the forecast period.
Grand View Research has segmented the global radiopharmaceuticals/nuclear medicine market on the basis of product, application, and region:
- Nuclear Medicine Product Outlook (Revenue, USD Million, 2014 - 2025)
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- RB-82
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Nuclear Medicine Application Outlook (Revenue, USD Million, 2014 - 2025)
- Diagnostics
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Others
- Therapeutics
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumor
- Others
- Nuclear Medicine Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Netherlands
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Singapore
- Korea
- Philippines
- Australia
- New Zealand
- Latin America
- Mexico
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- Israel
- Turkey
- North America
Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article